Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
105 hedge funds and large institutions have $255M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 11 closing their positions.
91% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 11
58% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 26
7% more funds holding
Funds holding: 98 → 105 (+7)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
34% less capital invested
Capital invested by funds: $385M → $255M (-$130M)
89% less call options, than puts
Call options by funds: $70K | Put options by funds: $611K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$16.8M |
| 2 |
AC
Armistice Capital
New York
|
+$10.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.76M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.61M |
| 5 |
Renaissance Technologies
New York
|
+$2.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$13.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.4M |
| 3 |
AG
Artal Group
Luxembourg
|
-$9.3M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.29M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.22M |
FMTX Hedge Fund Activity: Q2 2022 in Review
105 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q2 2022, worth a combined $255M — down 34% from $385M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new FMTX positions and 11 closed out — a net gain of 10 holders — while 41 added to existing stakes and 26 trimmed.
The largest buyer was Deep Track Capital, adding an estimated $16.8M. The largest seller was State Street, cutting an estimated $13.2M.
- 105 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q2 2022, up from 98 in Q1 2022.
- Funds reported $255M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q2 2022, down 34% quarter-over-quarter.
- 21 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q2 2022 and 11 closed out, a net change of +10 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q2 2022 was Deep Track Capital, an estimated $16.8M added.
- The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q2 2022 was State Street, an estimated $13.2M sold.
Based on aggregated 13F filings for Q2 2022.